Market Overview:
The global goodpasture syndrome treatment market is expected to register a CAGR of 7.5% during the forecast period 2018-2030. The market growth can be attributed to factors such as increasing incidence of autoimmune diseases, rising awareness about goodpasture syndrome and technological advancements in the field of diagnosis and treatment. However, high cost associated with diagnosis and treatment is expected to restrain the growth of this market during the forecast period. Based on type, corticosteroids are estimated to account for a major share in the global goodpasture syndrome treatment market in 2018. This can be attributed to their ability to suppress inflammation and control symptoms associated with Goodpasture Syndrome (GPS). Immunosuppressive drugs are also anticipated to witness significant growth during the forecast period owing to their ability prevent organ rejection in patients suffering from GPS. By application, hospital segment is estimated dominate the global goodpasture syndrome treatment market in 2018 followed by clinic segment. This can be attributed growing number of hospitals offering specialized services for GPS patients along with increasing awareness about this disease among people across different geographies .
Product Definition:
Goodpasture Syndrome is a rare autoimmune disorder that causes the body to attack its own lungs and kidneys. It can cause difficulty breathing, coughing up blood, and kidney failure. Treatment includes medications to suppress the immune system, such as corticosteroids and cyclophosphamide.
Corticosteroids:
Corticosteroids are the group of drugs which act as anti-inflammatory agents. They are used for the treatment of inflammation and in some cases, immune system diseases. Corticosteroid is a type of drug that reduces the inflammatory response by inhibiting cytokines production.
Immunosuppressive Drugs:
Immunosuppressive drugs are used in the treatment of Goodpasture syndrome (GPS) to reduce or eliminate inflammatory responses by suppressing the production of cytokines. The main aim of immunosuppressive drug therapy is to reduce the frequency and severity of clinical symptoms, as well as prevent tissue damage.
Application Insights:
Based on the application, the global goodpasture syndrome treatment market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of patients suffering from GSS at a global level coupled with increasing awareness about this disease among healthcare professionals at an international level.
The other applications include travel clinics and e-clinics that offer online medical consultation services for diagnosing and treating various diseases including goodpasture syndrome. Travel clinics are usually set up near hospitals or airports so that people affected by GSS can get prompt medical attention upon arrival at their destination without having to undergo extensive investigations first thing in the morning after traveling abroad for longer durations of time or short trips abroad which many patients find inconvenient owing to scheduling conflicts involved.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, availability of goodpasture syndrome treatment drugs, and high healthcare expenditure. In addition, increasing prevalence of asthma is expected to fuel the regional market growth over the forecast period. For instance, according to a study published by National Institute for Children’s Health Quality in 2018 regardingAsthma Management through Education and Support (MESSAGE) program initiated by NIAID-UCSF Asthma Program; it was observed that from 2011 to 2015 there was an increase of 10% in children with asthma across U.S.
Growth Factors:
- Increasing incidence of Goodpasture Syndrome
- Growing awareness about Goodpasture Syndrome and its treatment options
- Rising demand for better and more effective treatment options for Goodpasture Syndrome
- Technological advancements in the field of Goodpasture Syndrome treatment 5. Availability of government funding for research on new treatments forGoodpasture Syndrome
Scope Of The Report
Report Attributes
Report Details
Report Title
Goodpasture Syndrome Treatment Market Research Report
By Type
Corticosteroids, Immunosuppressive Drugs, Others
By Application
Hospital, Clinic, Others
By Companies
Amneal Pharmaceuticals, Bristol-Myers Squibb, Sandoz, Fibrostatin, Hansa Medical, Acer Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Goodpasture Syndrome Treatment Market Report Segments:
The global Goodpasture Syndrome Treatment market is segmented on the basis of:
Types
Corticosteroids, Immunosuppressive Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amneal Pharmaceuticals
- Bristol-Myers Squibb
- Sandoz
- Fibrostatin
- Hansa Medical
- Acer Therapeutics
Highlights of The Goodpasture Syndrome Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroids
- Immunosuppressive Drugs
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Goodpasture Syndrome Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for Goodpasture Syndrome, but the condition can be managed with a combination of supportive care and medication. Treatment may include antibiotics to fight infection, steroids to reduce inflammation, and pain relief medications. In some cases, surgery may be necessary to remove the infected tissue or repair damage caused by the syndrome.
Some of the major players in the goodpasture syndrome treatment market are Amneal Pharmaceuticals, Bristol-Myers Squibb, Sandoz, Fibrostatin, Hansa Medical, Acer Therapeutics.
The goodpasture syndrome treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Goodpasture Syndrome Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Goodpasture Syndrome Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Goodpasture Syndrome Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Goodpasture Syndrome Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Goodpasture Syndrome Treatment Market Size & Forecast, 2018-2028
4.5.1 Goodpasture Syndrome Treatment Market Size and Y-o-Y Growth
4.5.2 Goodpasture Syndrome Treatment Market Absolute $ Opportunity
Chapter 5 Global Goodpasture Syndrome Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Goodpasture Syndrome Treatment Market Size Forecast by Type
5.2.1 Corticosteroids
5.2.2 Immunosuppressive Drugs
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Goodpasture Syndrome Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Goodpasture Syndrome Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Goodpasture Syndrome Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Goodpasture Syndrome Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Goodpasture Syndrome Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Goodpasture Syndrome Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Goodpasture Syndrome Treatment Market Size Forecast by Type
9.6.1 Corticosteroids
9.6.2 Immunosuppressive Drugs
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Goodpasture Syndrome Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Goodpasture Syndrome Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Goodpasture Syndrome Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Goodpasture Syndrome Treatment Market Size Forecast by Type
10.6.1 Corticosteroids
10.6.2 Immunosuppressive Drugs
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Goodpasture Syndrome Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Goodpasture Syndrome Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Goodpasture Syndrome Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Goodpasture Syndrome Treatment Market Size Forecast by Type
11.6.1 Corticosteroids
11.6.2 Immunosuppressive Drugs
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Goodpasture Syndrome Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Goodpasture Syndrome Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Goodpasture Syndrome Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Goodpasture Syndrome Treatment Market Size Forecast by Type
12.6.1 Corticosteroids
12.6.2 Immunosuppressive Drugs
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Goodpasture Syndrome Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Goodpasture Syndrome Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Goodpasture Syndrome Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Goodpasture Syndrome Treatment Market Size Forecast by Type
13.6.1 Corticosteroids
13.6.2 Immunosuppressive Drugs
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Goodpasture Syndrome Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Goodpasture Syndrome Treatment Market: Competitive Dashboard
14.2 Global Goodpasture Syndrome Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amneal Pharmaceuticals
14.3.2 Bristol-Myers Squibb
14.3.3 Sandoz
14.3.4 Fibrostatin
14.3.5 Hansa Medical
14.3.6 Acer Therapeutics
